Anavex Life Sciences Corp (AVXL)

[Lenivec]

“Why All the Alzheimer's Drugs Fail, According to One Study. The Alzheimer's clinical trial success rate isn't pretty: A 99.6 percent failure rate means there are only four approved drugs to treat Alzheimer's on the market, and doctors say most of them are limited in terms of pushing back the symptoms of the disease”. But the good news is this would not be the first time AVXL is going against numbers like that.. remember AVXL started as a penny stock” Almost all penny stocks have a failure percentage of 100% and will inevitably move to 0 at some point. These companies usually have a terrible financial structure and are deemed to fail.” If AVXL drugs get approved they made impossible possible.